Currently, polymerase chain reaction, a DNA-based test, is used for detecting CRE, which are known for their ability to resist major antibiotics. However, these types of tests are expensive and require a lot of equipment.
The new test, known as Carba NP, is less expensive and takes just hours to produce results.
The Oregon State Public Health Lab researchers evaluated the ability of Carba NP to identify clinical isolates as carbapenemase producers. They achieved 100 percent sensitivity.
“We conclude that the Carba NP test is highly sensitive, specific and reproducible for the detection of carbapenemase production in a diverse group of organisms,” said Karim Morey of the Oregon State Public Health Lab.
More articles on infection control:
What insect’s bacteria could replace antibiotics?
Rare respiratory virus sweeping through US: What healthcare providers need to know
A new soldier in the war against HAIs: UV robots
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
